FTC Staff Warn 25 Health Plan Marketers, Alleging No Violation

FTC Staff Warn 25 Health Plan Marketers, Alleging No Violation

Federal Trade Commission staff sent warning letters on October 29, 2026 to 25 companies that market healthcare plans or generate sales leads for them. The agency states that the letters allege no wrongdoing by any recipient, and the FTC announced no enforcement action alongside them.

Information last verified on November 1, 2026. This is a developing story; we update it as the record changes.

Status: Warning letters issued October 29, 2026. FTC staff allege no violation by any recipient, the FTC announced no enforcement action, and the agency says it expects to send additional letters on a rolling basis.

Jurisdiction scope: This article addresses federal consumer protection law enforced by the Federal Trade Commission and the federal insurance regulations that determine when indemnity style coverage sits outside Affordable Care Act requirements. It does not address state insurance licensing, state unfair trade practice claims, or Medicare Advantage marketing rules, and it does not evaluate any company, plan or product.

What Happened

On October 29, 2026, staff in the FTC's Bureau of Consumer Protection sent warning letters to 25 companies that market healthcare plans or generate sales leads for them. The release is titled "FTC Staff Warn Marketers of Healthcare Plans and Lead Generators Not to Deceive Consumers about the Terms of the Advertised Plans."

The letters reach beyond Affordable Care Act Marketplace insurance. The release describes the covered products as including limited indemnity plans and medical discount programs. It also states that the agency "expects to send additional letters on a rolling basis."

The release is explicit about what the letters are not.

"The letters do not allege any wrongdoing by any of the recipients." Source: FTC press release, "FTC Staff Warn Marketers of Healthcare Plans and Lead Generators Not to Deceive Consumers about the Terms of the Advertised Plans," October 29, 2026

The FTC published no list of recipients and identified no company. Christopher Mufarrige, Director of the FTC's Bureau of Consumer Protection, is the official quoted in the release, which also states that the letters note the FTC is monitoring the marketplace.

The agency did publish a template of the letter itself, and that document carries the legal detail the press release leaves out. It is signed by Lois C. Greisman, Associate Director of the Division of Marketing Practices, and its subject line reads "Deceptive or Unfair Acts or Practices Relating to the Marketing, Advertising, and Lead Generation of Healthcare-Related Products, Including Healthcare Plans." The template restates the no-conclusion point in its own words.

"This letter is not intended to reflect an assessment or conclusion by the FTC staff that you or your company have engaged in illegal conduct." Source: FTC sample healthcare warning letter template, at 3

The template says FTC staff have identified a pattern of deceptive claims and lists four categories: misrepresenting the benefits included in a healthcare related product, including any insurance benefits; misrepresenting that such a product is major or comprehensive medical health insurance or the equivalent of such insurance; misrepresenting the costs of such products; and falsely claiming that consumers who enroll will receive free offers, cash rewards, rebates or other incentives.

The letter asks recipients to review their marketing, naming paid and other online ads, website representations, social media, promotional materials, and the conduct of third party distributors, marketing affiliates and sales agents. It sets no response deadline, demands no documents, and directs inquiries to a named FTC staff contact.

One terminology point matters for anyone comparing the release to insurance law. The release uses the phrase "limited indemnity plans" and the template uses "limited benefit plans." Neither phrase is a defined term in the federal insurance regulations discussed below, which address "hospital indemnity or other fixed indemnity insurance." The FTC documents are describing a marketing problem, not applying an insurance law category.

What the Law Actually Says

Three bodies of federal law sit behind these letters. The press release cites none of them; the published template cites all three.

Section 5 of the FTC Act. The operative provision is 15 U.S.C. 45(a)(1), which states that "[u]nfair methods of competition in or affecting commerce, and unfair or deceptive acts or practices in or affecting commerce, are hereby declared unlawful." Section 45(a)(2) empowers and directs the Commission to prevent persons, partnerships and corporations from using such practices, subject to carve outs that include banks, common carriers and air carriers. Insurance is not on that exemption list, though a separate statute, the McCarran-Ferguson Act, 15 U.S.C. 1012(b), applies the FTC Act to the business of insurance only to the extent that business is not regulated by state law. The marketers, lead generators and discount plan sellers the FTC has pursued in this market sit outside that limitation.

The Telemarketing Sales Rule. The template cites 16 C.F.R. § 310.4(b)(1). That paragraph makes each of several listed practices, on its own, both an abusive telemarketing act or practice and a violation of the rule, whether the telemarketer does it or the seller causes a telemarketer to do it. Subparagraph (b)(1)(iii)(B) covers calling a number on the Commission's do-not-call registry unless the seller can demonstrate express written agreement or an established business relationship. Subparagraph (b)(1)(v) covers outbound calls delivering a prerecorded message to induce a purchase without the recipient's express written agreement. Unsolicited health plan robocalls are the practice the letter ties to this rule.

The Impersonation Rule. 16 C.F.R. § 461.2 makes it a violation of the rule, and an unfair or deceptive act or practice, to materially and falsely pose as a government entity or officer, or to materially misrepresent affiliation with, endorsement by or sponsorship by one. Section 461.3 does the same for businesses. The rule was published at 89 FR 15017 on March 1, 2024, took effect on April 1, 2024, and appears in the CFR from 89 FR 15030. The letter gives the Department of Health and Human Services and insurance carriers as examples of the government agencies and businesses a marketer may not falsely pose as or claim affiliation with.

What a violation can cost, and what it cannot. This distinction is easy to blur. Civil penalties under Section 5(m)(1)(A), 15 U.S.C. 45(m)(1)(A), attach to a knowing violation of a rule respecting unfair or deceptive acts or practices, which here means the Telemarketing Sales Rule or the Impersonation Rule rather than a bare Section 5 deception theory. The FTC's inflation adjustment effective January 17, 2025 set the maximum at $53,088 per violation, and in a notice published September 15, 2026 the agency stated that its civil penalty amounts "will remain unchanged during 2026." Separately, Section 19(b), 15 U.S.C. 57b(b), gives a court jurisdiction in a rule violation case to grant relief including "rescission or reformation of contracts, the refund of money or return of property, the payment of damages, and public notification respecting the rule violation or the unfair or deceptive act or practice," while expressly not authorizing exemplary or punitive damages.

Fixed indemnity coverage is not comprehensive insurance, and federal regulation requires a notice that says so. Under 45 C.F.R. § 148.220(b)(4), hospital indemnity or other fixed indemnity insurance is an excepted benefit in the individual market, and therefore outside most of the requirements of 45 C.F.R. parts 147 and 148, only if there is no coordination with other health coverage, benefits are paid in a fixed dollar amount per period of hospitalization or illness or per service regardless of expenses incurred, and the issuer displays a required notice. Which notice is currently required is not what the published regulation appears to say.

A Treasury, Labor and HHS final rule at 89 FR 23338, published April 3, 2024 and effective June 17, 2024, added a new notice condition for coverage periods beginning on or after January 1, 2025. It would have required a 14-point notice headed "IMPORTANT: This is a fixed indemnity policy, NOT health insurance" on the first page of marketing, application and enrollment or reenrollment materials and on the first page of the policy. That provision never applied to anyone.

On December 4, 2024 the United States District Court for the Eastern District of Texas set aside and vacated the rule's compelled-notice provisions, naming "the provision revising 45 C.F.R. § 148.220(b)(4)(iii)," and the government's appeal was dismissed on its own unopposed motion on June 10, 2025 (ManhattanLife Insurance and Annuity Co. v. U.S. Department of Health and Human Services, No. 6:24-cv-00178-JCB (E.D. Tex.), final judgment; 5th Cir. No. 25-40072). The published CFR text still prints the vacated language, because the agencies have not amended the regulation to match the judgment, so reading the regulation on its own gives the wrong answer here. The same judgment also set aside the rule's language rescinding the 2014 notice requirement in the individual market, holding that the rescission "is not severable from the rule's creation of new compelled-notice language, so they must be set aside and vacated together."

What applies in the individual market is the earlier notice the same judgment preserved, at 45 C.F.R. § 148.220(b)(4)(iv) as revised as of October 1, 2023, which requires, in at least 14 point type in the application materials:

"THIS IS A SUPPLEMENT TO HEALTH INSURANCE AND IS NOT A SUBSTITUTE FOR MAJOR MEDICAL COVERAGE. LACK OF MAJOR MEDICAL COVERAGE (OR OTHER MINIMUM ESSENTIAL COVERAGE) MAY RESULT IN AN ADDITIONAL PAYMENT WITH YOUR TAXES." Source: 45 C.F.R. § 148.220(b)(4)(iv), as revised as of October 1, 2023, applicable to fixed indemnity policy years beginning on or after January 1, 2015

The vacated 2024 notice would have gone further. As published, it said that the policy "may pay you a limited dollar amount if you're sick or hospitalized," that "[y]ou're still responsible for paying the cost of your care," and that the policy "isn't a substitute for comprehensive health insurance," and it pointed readers to HealthCare.gov and to their state department of insurance, all on the first page of the marketing materials and of the policy (89 FR 23338, 23421). Because it was set aside, none of that is required of any issuer today.

Medical discount programs are a different category again. They are not insurance at all. The FTC's consumer resource on the subject states that "[m]edical discount plans aren't health insurance, and they're not a substitute for it," and that "[s]ome medical discount plans provide legitimate discounts, but some are just flat-out scams." That same guidance tells consumers to research the company and the plan before paying any money, warns that a marketer who will not put the plan in writing or who pressures an immediate purchase is a warning sign, and points to the state insurance commissioner, the Better Business Bureau and state law enforcement. Our guide to Medicare and health insurance scams covers the related Medicare side of this market, and the general pattern recognition questions are collected in how to tell if something is a scam.

Enrollment timing is where consumers are most exposed, so it is worth stating precisely. As read on November 1, 2026, HealthCare.gov states "November 1: Open Enrollment starts," that consumers should "[e]nroll by December 15 for coverage that starts January 1," and "January 15: Open Enrollment ends." The CFR still prints a conflicting rule, and for the same reason it does at section 148.220. A 2025 final rule added 45 C.F.R. § 155.410(e)(5), which would require the annual open enrollment period for all Exchanges to end no later than December 31 of the preceding calendar year and to run no more than nine weeks for benefit years beginning on or after January 1, 2027. On June 12, 2026 the United States District Court for the District of Maryland vacated that provision along with eight others in City of Columbus v. Kennedy, No. 1:25-cv-2114 (D. Md.), and the government's appeal in the Fourth Circuit, No. 26-1938, lists the open enrollment period among the issues it is contesting. CMS has since stated that HHS has not altered the open enrollment dates in 45 C.F.R. § 155.410(e)(4) and that open enrollment at the Federally-facilitated Marketplace runs November 1, 2026 through January 15, 2027. State based Exchanges run their own windows. The practical consequence is narrow and important: the deadline that governs a given consumer is the one published by HealthCare.gov or by that consumer's state Marketplace, not a date quoted in an advertisement or by a caller.

Analysis: Why This Matters

The following is analysis from the Recording Law Editorial Team.

A warning letter is among the lightest instruments the FTC uses. It creates no finding, no order, no penalty and no admission, and the agency said in plain terms that these 25 letters allege nothing against anyone. Read only through the press release, the story is thin.

Read through the published template, it is more substantial, because the template is a compliance roadmap the agency chose to make public. It identifies the exact claim categories staff say they have seen, names three sources of liability, and lists eight prior matters with their dockets and outcomes. Two of those matters, which the letter describes as ongoing, are cases in which the letter says the court entered a preliminary injunction. A preliminary injunction is not a final merits ruling and decides no claim; it is interim relief pending litigation.

The pattern across the letter's case list is consistent, and it is the same pattern the four flagged claim categories describe: a product that pays a fixed amount or discounts a provider's fee, sold as though it were comprehensive coverage. The product-side answer to that confusion was supposed to be the 2024 fixed indemnity notice rule, which would have forced a plain-language disclosure onto the first page of the marketing materials and of the policy. A court vacated it before it applied, which leaves the older and weaker supplement notice in the application materials as the only product-side disclosure in the individual market. That puts more of the weight on Section 5, which works on the marketing instead, by making the misrepresentation itself actionable. The two mechanisms never depended on each other, and a product can carry a compliant notice and still be marketed deceptively.

One structural feature of the statute deserves flagging without prediction. Section 5(m)(1)(A) conditions civil penalties on a knowing violation of a rule, and the template puts the Telemarketing Sales Rule and the Impersonation Rule in front of each recipient in writing. We state what the statute requires and what the letter contains; we do not forecast how any court would treat the letter in any future case, and none has been filed.

The timing is also worth noting. The letters went out on October 29, three days before the HealthCare.gov Marketplace open enrollment period opened on November 1, and the release describes them as going out with open enrollment season for healthcare plans in progress. The agency framed the letters as preventive rather than punitive, and the template says staff will continue to monitor the market.

How This Affects You

Nothing in these letters tells a consumer anything about any specific company, because no recipient was named and no violation was alleged. Treating a warning letter as evidence against a business would be a misreading of the document.

What the letters and the underlying regulations do supply is a short list of the questions federal law treats as material. Is the product comprehensive health insurance, or something else. What does it actually pay, and on what basis. What does it cost in total. Is any promised reward, rebate or free offer real.

The fixed indemnity notice requirement gives readers one concrete, checkable fact, as long as it is the right notice. An issuer of fixed indemnity coverage sold as an excepted benefit in the individual market must display, in at least 14 point type in its application materials, the notice at 45 C.F.R. § 148.220(b)(4)(iv) stating that the coverage is a supplement to health insurance and is not a substitute for major medical coverage. Whether that language appears in the application materials is something a person can observe directly. The stronger 2024 notice, the one headed "IMPORTANT: This is a fixed indemnity policy, NOT health insurance," was vacated before it ever applied, so its absence from a marketing page proves nothing about the product.

On reporting, the FTC release directs consumers to reportfraud.ftc.gov and to the FTC Consumer Response Center at 877-382-4357. The FTC's medical discount plan guidance additionally points to state insurance commissioners, the Better Business Bureau and state law enforcement. Which agency fits which complaint, and what recovery realistically looks like, is covered in where to report a scam and whether money can be recovered. Because this market also involves false claims of government affiliation, the overlapping pattern is covered in our guide to government impersonation scams, and the general post incident steps are in what to do after a scam.

On timing, confirm the enrollment deadline that applies to you on HealthCare.gov or your state Marketplace rather than relying on a date given in a pitch. As noted above, the CFR still prints a shortened window at 45 C.F.R. § 155.410(e)(5) that a federal court vacated in June 2026, so the published HealthCare.gov dates, not the regulation as printed, are the ones that govern.

What Happens Next

The status has not changed and will not change by itself. As of November 1, 2026 there are 25 warning letters, no allegation against any recipient, and no enforcement action announced.

Three things could move the record. First, more letters: the release states the agency expects to send additional letters on a rolling basis, and each new batch would carry the same no-allegation posture. Second, an enforcement filing: the only event that would turn this into a completed legal step is the FTC filing a complaint in federal district court or the Commission issuing an administrative complaint against a specific company, and even then a complaint is an allegation that the respondent is entitled to contest. Third, the eight matters listed in the template continue on their own schedules, including the two the letter describes as ongoing litigation under preliminary injunctions.

Two dated items are worth re-checking. The FTC stated on September 15, 2026 that its civil penalty amounts remain unchanged during 2026, so the $53,088 maximum is current but is the kind of number that moves with an annual inflation adjustment. And the Marketplace enrollment deadline for 2027 coverage should be reconfirmed against HealthCare.gov or the relevant state Marketplace before anyone relies on it.

This is general legal information, not legal advice. It covers federal law of the United States, specifically the Federal Trade Commission Act and rules enforced by the FTC, and the federal insurance regulations governing excepted benefits and Exchange enrollment periods, and reflects sources verified on November 1, 2026. Laws change and this story is developing; consult a lawyer licensed in your jurisdiction about your specific situation.

Related articles

• Medicare and health insurance scams: warning signs and reporting
• How to tell if something is a scam
• Where to report a scam, and whether you can get money back
• Government impersonation scams involving federal agencies
• I got scammed: what to do next

---

Last updated: 2026-11-01. This is a developing story; details verified as of 2026-11-01.

Frequently Asked Questions

Did the FTC accuse these 25 companies of breaking the law?

No. The FTC's October 29, 2026 press release states that the letters do not allege any wrongdoing by any of the recipients, and the published letter template states that it is not intended to reflect an assessment or conclusion by FTC staff that the recipient engaged in illegal conduct. The FTC announced no enforcement action alongside the letters, and because it named no recipient, no company can be matched to any docket.

Which companies received the FTC warning letters?

The FTC did not publish a recipient list and named no recipient in the release, so the companies are not publicly identified from this announcement. Any list circulating elsewhere does not come from the October 29, 2026 release.

What law does the FTC say applies to healthcare plan marketing?

The press release names no statute. The published letter template cites Section 5(a) of the FTC Act, 15 U.S.C. 45(a), which declares unfair or deceptive acts or practices in or affecting commerce unlawful, the Telemarketing Sales Rule at 16 CFR 310.4(b)(1), and the Rule on Impersonation of Government and Businesses at 16 CFR Part 461.

Is a fixed indemnity plan the same as health insurance?

Federal regulation treats it as a separate category. Under 45 CFR 148.220(b)(4), hospital indemnity or other fixed indemnity insurance is an excepted benefit outside most Affordable Care Act requirements, and the notice federal regulation requires in the application materials states that the coverage is a supplement to health insurance and is not a substitute for major medical coverage. The stronger notice adopted at 89 FR 23338 in 2024 was vacated by a federal court and never took effect.

Is a medical discount program insurance?

No. The FTC's consumer guidance states that medical discount plans are not health insurance and are not a substitute for it, and that while some provide legitimate discounts, some are scams. The guidance advises researching the company and the plan before paying any money, and names pressure to buy immediately as a warning sign.

What notice is a fixed indemnity policy required to display?

The operative requirement is 45 CFR 148.220(b)(4)(iv), revised as of October 1, 2023, which requires a notice in at least 14 point type in the application materials stating that the coverage is a supplement to health insurance and is not a substitute for major medical coverage. The notice at 45 CFR 148.220(b)(4)(iii)(A), which the 2024 rule added for coverage periods beginning on or after January 1, 2025 and which would have appeared on the first page of marketing materials and of the policy, was set aside and vacated on December 4, 2024 in ManhattanLife Insurance and Annuity Co. v. HHS, and the government's appeal was dismissed in June 2025. The CFR as published still prints the vacated text.

When is open enrollment for 2027 Marketplace coverage?

HealthCare.gov stated on November 1, 2026 that open enrollment starts November 1, that enrolling by December 15 starts coverage January 1, and that open enrollment ends January 15. The CFR still prints a shorter window at 45 CFR 155.410(e)(5) for benefit years beginning on or after January 1, 2027, but a federal court vacated that provision in June 2026 and CMS has confirmed the dates are unchanged. State Exchanges set their own windows, so confirm the deadline on HealthCare.gov or your state Marketplace.

What penalty can the FTC seek in this area?

Civil penalties under 15 U.S.C. 45(m)(1)(A) apply to a knowing violation of a rule respecting unfair or deceptive acts or practices, capped at a maximum of $53,088 per violation and left unchanged for 2026 by a notice published September 15, 2026. In a rule violation case a court may also order relief under 15 U.S.C. 57b(b), including refunds and rescission of contracts.

Where do I report a deceptive health plan pitch?

The FTC release directs consumers to reportfraud.ftc.gov and to the FTC Consumer Response Center at 877-382-4357. The FTC's medical discount plan guidance also points consumers to state insurance commissioners and state attorneys general; which office fits a given complaint depends on the conduct and the state.

Does a preliminary injunction in the cases the FTC lists mean those companies lost?

No. The letter describes two of the listed matters as ongoing litigation in which the court entered a preliminary injunction. A preliminary injunction is interim relief pending litigation and is not a final ruling on the merits of any claim.